This study sought to describe the economic outcomes from a prospective multicenter registry of primary coronary angioplasty.
Interest in coronary angioplasty without preceding thrombolytic therapy as a primary reperfusion strategy has increased as a result of three recent randomized trials showing outcomes equivalent to or better than standard thrombolytic therapy.
The Primary Angioplasty Registry enrolled 270 patients with acute myocardial infarction at six private tertiary care medical centers.
Baseline and follow-up medical costs and counts of resources consumed were collected from enrollment to the 6-month follow-up visit.
Correlates and predictors of cost were identified with multivariable linear regression modeling.
Ninety-five percent of patients had a revascularization procedure during the baseline hospital period :
85% had coronary angioplasty only ;
4% had coronary bypass surgery only ;
6% had both procedures.
Costs of primary angioplasty for patients with acute myocardial infarction eligible for thrombolysis were strongly influenced by infarction-and procedure-related complications but only modestly influenced by patient selection factors.
Mots-clés Pascal : Infarctus, Myocarde, Homme, Dilatation instrumentale, Artère coronaire, Coût, Economie santé, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie, Traitement instrumental
Mots-clés Pascal anglais : Infarct, Myocardium, Human, Instrumental dilatation, Coronary artery, Costs, Health economy, Cardiovascular disease, Coronary heart disease, Myocardial disease, Instrumentation therapy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0517941
Code Inist : 002B12A03. Création : 01/03/1996.